CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Strong antiviral effect of the combination therapy (entecavir and tenofovir) in treatment experienced chronic HBV-mono infected patients with multidrug resistance or only partial responses to previous lines of therapy and advanced liver di…
DOI 10.1055/s-0029-1191951
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Schollmeyer, M Lütgehetmann, T Volz, AW Lohse, S Polywka, T Meyer, M Dandri, J Petersen
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Treatment of chronic HBV infected individuals with nucleos(t)ide analogs using sequential monotherapy has led to the selection of multiple resistant mutations, endangering patients with advanced liver disease. The aim of this cohort study was to investigate the efficacy and safety of tenofovir (245mg) and entecavir (1mg) in treatment experienced patients with multidrug resistant HBV or only partial responses to prev…
Zitieren
Zitierempfehlung
J Schollmeyer, M Lütgehetmann, T Volz, AW Lohse, S Polywka, T Meyer, M Dandri, J Petersen (2009) Strong antiviral effect of the combination therapy (entecavir and tenofovir) in treatment experienced chronic HBV-mono infected patients with multidrug resistance or only partial responses to previous lines of therapy and advanced liver disease. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0029-1191951
Mit CareLit weiterarbeiten